Tag: Redhill

RedHill Biopharma completes enrollment of oral opaganib phase 2/3 COVID-19 study

Bioengineer June 7, 2021

The global phase 2/3 study of orally-administered opaganib for the treatment of severe COVID-19 enrolled a total of 475 patients, more than the...

Top News

Clean Energy Technologies, Inc. Enters MOU for $15M Biomass Renewable Energy Project

Energy April 29, 2021

RedHill announces compassionate use treatment with opaganib of Swiss COVID-19 patients

Bioengineer March 22, 2021

CETY Enters China’s Rapidly Growing Clean Energy Market by Signing Joint Venture Agreement with Major Chinese Clean Energy Conglomerate

Energy September 16, 2020

No posts to display

Latest Intelligence

spot_img

spot_img